HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yong Zhu Selected Research

n-pentanoic acid (valeric acid)

1/2021Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications.
12/2020Valeric Acid Suppresses Liver Cancer Development by Acting as a Novel HDAC Inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yong Zhu Research Topics

Disease

106Neoplasms (Cancer)
08/2022 - 05/2002
34Breast Neoplasms (Breast Cancer)
01/2022 - 12/2004
21Infections
01/2022 - 11/2004
19Carcinogenesis
05/2022 - 01/2006
15Neoplasm Metastasis (Metastasis)
01/2021 - 02/2004
12Carcinoma (Carcinomatosis)
01/2019 - 02/2002
11Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2014 - 05/2004
10Pancreatitis
01/2022 - 01/2016
10Inflammation (Inflammations)
01/2022 - 05/2013
10Pulmonary Fibrosis (Fibrosing Alveolitis)
12/2021 - 02/2016
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 10/2008
9Poisoning
08/2021 - 04/2016
9Burns
11/2015 - 12/2010
8Stomach Neoplasms (Stomach Cancer)
01/2022 - 02/2017
8Lung Neoplasms (Lung Cancer)
01/2022 - 10/2008
8Tuberculosis (Tuberculoses)
01/2022 - 08/2013
7Hypoxia (Hypoxemia)
05/2022 - 01/2017
7Scoliosis
03/2020 - 02/2011
6Coronary Artery Disease (Coronary Atherosclerosis)
04/2022 - 04/2018
6Hepatocellular Carcinoma (Hepatoma)
02/2022 - 02/2004
6Spinal Tuberculosis (Pott's Disease)
01/2022 - 01/2018
6Acute Necrotizing Pancreatitis
12/2021 - 01/2017
6Osteoarthritis
01/2021 - 01/2003
6Prostatic Neoplasms (Prostate Cancer)
01/2020 - 01/2006
6Osteosarcoma (Osteogenic Sarcoma)
11/2019 - 12/2010
5Hemorrhage
12/2021 - 12/2013
5Infertility (Sterility)
03/2021 - 12/2013
5Spinal Injuries (Spinal Injury)
01/2021 - 01/2017
5Wounds and Injuries (Trauma)
12/2019 - 10/2015
5Urinary Bladder Neoplasms (Bladder Cancer)
04/2008 - 03/2003
4Pulmonary Tuberculosis
11/2022 - 09/2021
4Colorectal Neoplasms (Colorectal Cancer)
10/2022 - 01/2018
4Type 2 Diabetes Mellitus (MODY)
04/2022 - 04/2018
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2022 - 02/2008
4Insulin Resistance
01/2022 - 06/2015
4Glioma (Gliomas)
08/2021 - 01/2016
4Myocardial Infarction
01/2021 - 02/2006
4Postoperative Hemorrhage
01/2021 - 05/2015
4Congenital Abnormalities (Deformity)
03/2019 - 03/2009
4Hemorrhagic Fever with Renal Syndrome (HFRS)
01/2009 - 11/2004
3Body Weight (Weight, Body)
11/2022 - 06/2015
3Acute Coronary Syndrome
08/2022 - 01/2020
3Ischemia
05/2022 - 01/2020
3Adenocarcinoma of Lung
04/2022 - 07/2018
3Male Infertility (Male Sterility)
01/2022 - 08/2016
3Atrial Fibrillation
01/2022 - 01/2021
3Diabetes Mellitus
01/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

37Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2002
23Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2002
22Biological ProductsIBA
01/2021 - 01/2007
20MicroRNAs (MicroRNA)IBA
12/2021 - 04/2008
11Pharmaceutical PreparationsIBA
08/2022 - 06/2016
10SmokeIBA
05/2014 - 08/2002
9Long Noncoding RNAIBA
01/2022 - 09/2017
9ParaquatIBA
08/2021 - 02/2016
9DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2005
9Hormones (Hormone)IBA
01/2019 - 01/2006
8C-Reactive ProteinIBA
01/2022 - 06/2015
8Glucose (Dextrose)FDA LinkGeneric
12/2021 - 08/2014
8Progesterone Receptors (Progesterone Receptor)IBA
01/2020 - 08/2006
7Histone Deacetylase InhibitorsIBA
10/2022 - 01/2019
7Messenger RNA (mRNA)IBA
01/2020 - 05/2004
6Histone Deacetylases (Histone Deacetylase)IBA
08/2022 - 01/2019
6Insulin (Novolin)FDA Link
12/2021 - 01/2013
6CollagenIBA
12/2021 - 02/2006
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 02/2004
6CytokinesIBA
05/2017 - 01/2003
5Triglycerides (Triacylglycerol)IBA
10/2021 - 10/2016
5AntibodiesIBA
01/2021 - 03/2005
5LipidsIBA
12/2020 - 06/2015
5EnzymesIBA
04/2020 - 05/2005
5Progestins (Progestagens)IBA
10/2019 - 11/2008
5Piwi-Interacting RNAIBA
12/2018 - 10/2015
4AlbuminsIBA
11/2022 - 04/2017
4Serum AlbuminIBA
11/2022 - 09/2021
4Therapeutic UsesIBA
02/2022 - 04/2017
4Estrogen ReceptorsIBA
01/2022 - 02/2010
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 01/2003
4RNA (Ribonucleic Acid)IBA
01/2021 - 05/2004
4Interleukin-6 (Interleukin 6)IBA
01/2021 - 11/2004
4Peptides (Polypeptides)IBA
01/2021 - 11/2005
4Doxorubicin (Adriamycin)FDA LinkGeneric
02/2020 - 02/2011
4CryptochromesIBA
05/2015 - 04/2009
4LigandsIBA
01/2008 - 02/2002
47,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideIBA
12/2004 - 05/2002
3Carcinoembryonic AntigenIBA
01/2022 - 02/2019
3Estrogens (Estrogen)FDA Link
01/2022 - 05/2004
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2022 - 11/2014
3Hemoglobins (Hemoglobin)IBA
01/2022 - 05/2002
3Bleomycin (Blenoxane)FDA LinkGeneric
12/2021 - 07/2002

Therapy/Procedure

34Therapeutics
04/2022 - 01/2007
12Debridement
01/2022 - 02/2011
7Percutaneous Coronary Intervention
01/2021 - 04/2018
6Stents
08/2022 - 04/2018
6Length of Stay
01/2021 - 05/2015
6Decompression
03/2020 - 09/2009
5Drug Therapy (Chemotherapy)
01/2022 - 10/2012
4Chinese Traditional Medicine (Traditional Chinese Medicine)
03/2022 - 07/2018
4Immunotherapy
01/2022 - 01/2020
4Segmental Mastectomy (Lumpectomy)
05/2019 - 03/2016